CFD
SRPT icon

Creative Financial Designs’s Sarepta Therapeutics SRPT Stock Holding History

Creative Financial Designs’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-89
Closed -$8K – 1422
2021
Q3 		$8K Hold
89
– – ﹤0.01% 1069
2021
Q2 		$7K Hold
89
– – ﹤0.01% 1097
2021
Q1 		$7K Hold
89
– – ﹤0.01% 1002
2020
Q4 		$15K Hold
89
– – ﹤0.01% 779
2020
Q3 		$12K Hold
89
– – ﹤0.01% 775
2020
Q2 		$14K Buy
+89
New +$12.1K ﹤0.01% 679

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Creative Financial Designs's SRPT Position: Q4 2021 in Review

Creative Financial Designs sold out of Sarepta Therapeutics (SRPT) in Q4 2021, closing a stake of 89 shares — an estimated $8K sold.

Creative Financial Designs first reported a position in SRPT in Q2 2020 and held it in 6 quarters. The position peaked at $15K in Q4 2020. 343 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

  • Creative Financial Designs reported no remaining Sarepta Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Creative Financial Designs sold 89 Sarepta Therapeutics shares in Q4 2021, an estimated $8K.
  • Creative Financial Designs first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 6 quarters.
  • Creative Financial Designs's Sarepta Therapeutics position peaked at $15K in Q4 2020.
  • 343 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.